Patents
Patents for C07K - Peptides (3,738)
02/2015
02/10/2015US8951734 Prion-like form of CPEB and related compositions and methods
01/2015
01/28/2015CN104311658A 新的受体核酸及多肽 The new receptor nucleic acids and peptides
01/27/2015US8940695 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
01/15/2015US20150018409 Chimeric polypeptides and their use
01/08/2015US20150010946 Polynucleotides encoding zcytor17 ligand antibodies
01/06/2015CA2421998C Vaccine against streptococcus pneumoniae
12/2014
12/30/2014USRE45313 Exendin variant peptides
12/23/2014US8916522 FGF-9 variants and methods of use thereof
12/11/2014US20140364584 Skin or hair binding peptides
12/11/2014US20140363854 Thermostable reverse transcriptases and uses thereof
11/2014
11/13/2014US20140336356 Peptide agonists of glp-1 activity
11/04/2014US8877914 Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes
10/2014
10/14/2014US8859456 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
10/07/2014US8853364 Prostate stem cell antigen (PSCA) variants and subsequences thereof
10/07/2014US8853161 Glycopegylation methods and proteins/peptides produced by the methods
10/02/2014US20140296160 Stabilized alpha helical peptides and uses thereof
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/02/2014US20140294762 Glycopegylation methods and proteins/peptides produced by the methods
09/2014
09/25/2014US20140286941 Treatment of tnfalpha related disorders
09/25/2014US20140286940 Treatment of tnfalpha related disorders
09/25/2014US20140286939 Treatment of tnfalpha related disorders
08/2014
08/26/2014US8816048 Skin or hair binding peptides
08/26/2014US8815501 Flavivirus NS1 subunit vaccine
08/06/2014CN101670105B 螯合淀粉样蛋白β肽的人源化抗体 Human amyloid β peptide chelating humanized antibody
08/05/2014US8796418 Stabilized alpha helical peptides and uses thereof
08/05/2014CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine
07/2014
07/29/2014CA2697205C Peptidomimetic protease inhibitors
07/29/2014CA2567109C Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities
07/23/2014CN101090729B 前列腺干细胞抗原(psca)变体及其序列 Prostate stem cell antigen (psca) and sequence variants
07/15/2014US8778344 Method of treating atopic dermatitis with antibody to zcytor17 ligand
07/03/2014US20140187485 Novel receptor nucleic acids and polypeptides
06/2014
06/17/2014US8753845 Thermostable reverse transcriptases and uses thereof
06/10/2014CA2522753C Immuno-amplification
06/05/2014US20140155496 Templated Native Silk Smectic Gels
05/2014
05/28/2014CN1840178B 肿瘤特异性动物蛋白 Tumor-specific animal protein
05/27/2014US8735341 Non-viral delivery of compounds to mitochondria
05/27/2014CA2298855C Interleukin-18 binding proteins, their preparation and use
05/22/2014US20140141064 Hla-a2 tumor associated antigen peptides and compositions
05/21/2014CN101675992B β-淀粉样蛋白-类似物-T-细胞表位疫苗 β- amyloid - like -T- cell epitope vaccine
05/15/2014US20140135260 Ghrelin Analogs
05/13/2014CA2523998C Novel antimicrobial peptides
04/2014
04/22/2014US8703503 Methods and compositions for inhibition of BCL6 repression
04/17/2014US20140106341 Stabilized bioactive peptides and methods of identification, synthesis, and use
04/17/2014US20140105854 Vaccine for treatment and prevention of herpes simplex virus infection
04/10/2014US20140099339 Vaccine against streptococcus pneumoniae
04/09/2014CN102367277B Polymer conjugates of mutated neublastin
04/02/2014CN102241742B Peptides and compounds that bind to a thrombopoietin receptor
03/2014
03/26/2014EP2711025A2 Self-assembling peptides incorporating modifications and methods of use thereof
03/20/2014US20140080996 Skin or hair binding peptides
02/2014
02/18/2014CA2548310C Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
01/2014
01/21/2014US8633151 Ghrelin analogs
12/2013
12/25/2013CN103467588A Stabilized alpha helical peptides and uses thereof
12/24/2013CA2520372C Stq-peptides
12/19/2013US20130338070 Fgf-9 variants and methods of use thereof
12/18/2013EP2246362B1 Polymer conjugates of mutated neublastin
12/18/2013CN103450360A Antibodies to cd40
12/17/2013US8609823 FGF-9 variants and methods for use thereof
11/2013
11/26/2013US8591894 Humanized antibodies that sequester amyloid beta peptide
11/26/2013CA2482744C Hiv envelope-cd4 complexes and hybrids
11/21/2013US20130310320 Boronic ester and acid compounds, synthesis and uses
11/21/2013US20130309260 Human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
11/20/2013EP1565203B1 Templated native silk smectic gels
11/19/2013US8586033 Integrin αIIbβ3 specific antibodies and peptides
11/13/2013EP2374894A9 A method for producing influenza hemagglutinin multivalent vaccines
11/12/2013US8580924 Templated native silk smectic gels
10/2013
10/29/2013CA2466128C Antibodies to cd40
10/15/2013CA2483602C Fgf variants and methods for use thereof
10/08/2013US8552016 Anti-cancer cyclopenta(g)quinazoline compounds
10/08/2013US8551954 Antimicrobial peptides with heparin binding activity
10/01/2013US8546528 Skin or hair binding peptides
10/01/2013CA2514510C Polymer conjugates of mutated neublastin
09/2013
09/24/2013US8541002 Vaccine for treatment and prevention of herpes simplex virus infection
09/19/2013US20130243786 Treatment of juvenile rheumatoid arthritis (jra)
09/19/2013US20130243763 TREATMENT OF HIDRADENITIS SUPPURATIVA (HS) USING TNFalpha ANTIBODIES
09/12/2013US20130236452 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
09/10/2013US8529882 Peptidomimetic protease inhibitors
09/04/2013EP1680443B1 Stabilized alpha helical peptides and uses thereof
09/04/2013CN1622995B Receptor nucleic acids and polypeptides
09/04/2013CN103272219A Selective r-cadherin antagonists and methods
09/04/2013CN101633689B Peptide selection method
09/03/2013US8524672 Method for inhibiting BAFF-R activity
08/2013
08/15/2013US20130210722 Methods for using peptide agonists having glp-1 activity
08/07/2013CN103232381A Peptidomimetic protease inhibitors
08/06/2013US8501424 Cd4+ epitopes of bone morphogenetic proteins
07/2013
07/31/2013EP1476185B1 Antibodies to cd40
07/25/2013US20130189219 N-terminally chemically modified protein compositions and methods
07/16/2013US8486955 Anti-cancer cyclopenta [g] quinazoline compounds
07/09/2013CA2520323C Tie-2 modulators and methods of use
07/03/2013CN101502648B Vaccine
07/03/2013CN101445555B Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
06/2013
06/25/2013US8471006 Coupling agents for peptide synthesis
06/25/2013US8470334 Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics
06/20/2013US20130157337 Template-directed assembly of receptor signaling complexes
06/20/2013US20130156798 Peptide composition
06/20/2013US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases
06/18/2013CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
06/18/2013CA2422002C Vaccine
06/12/2013CN1812804B Selective r-cadherin antagonist and methods
05/2013
05/29/2013CN1582165B Antibodies to CD40
05/28/2013US8450333 Molecules for regulating cell death
1 2 3 4 5 6 7 8 9 10 11 ... 38